1-2 of 2
Antonio Perez, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized, Double-Blind, Phase III Study Comparing Proposed Biosimilar Rituximab (RTXM83) Versus Reference Rituximab, Both in Combination with CHOP, in the First Line Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

Myrna Candelaria, MDPharmD, Derlis Emilio Gonzalez, MD, Surender Kumar Beniwal, MD DM, Lokanatha Dasappa, MD, Daniel Oscar Bar, MD, Marcia Torresan Delamain, Ashis Mukhopadhyay, MD, David Hugo Flores, MD, Dinesh Bhurani, MD DM, FRCPA, Venkatraman Radhakrishnan, MD DM, Alejandro Salvatierra, MD, Ruben Dario Kowalyszyn, MD, Oleg Lipatov, MD, Moosa Patel, MD, Sergio Schusterschitz, MD, Elena Volodicheva, MD, Luis Antonio Perez, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1556.
https://doi.org/10.1182/blood.V130.Suppl_1.1556.1556
Published: 2017
Journal Articles

Early “Mini” Donor Lymphocyte Infusions after Reduced-Intensity Conditioning in Allogeneic Transplant of Highly Purified CD34 + Cells from HLA-Identical Donors in Pediatric Leukemia Patients.

Miguel A. Diaz, MD, PhD, Marta Gonzalez-Vicent, MD, PhD, Manuel Ramirez, MD, PhD, Antonio Perez, MD, Javier Garcia-Castro, PhD, Julian Sevila, MD, PhD, Luis Madero, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5387.
https://doi.org/10.1182/blood.V106.11.5387.5387
Published: 2005